• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Omega Reports Second Quarter 2024 Results and Recent Developments

    8/1/24 4:15:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate
    Get the next $OHI alert in real time by email

    Completed $648 Million in New Investments Year-to-Date

    Increased Full Year Adjusted FFO Guidance

    Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended June 30, 2024.

    SECOND QUARTER 2024 AND RECENT HIGHLIGHTS

    • Net income for the quarter of $117 million, or $0.45 per common share, compared to $62 million, or $0.25 per common share, for Q2 2023.
    • Nareit Funds From Operations ("Nareit FFO") for the quarter of $189 million, or $0.72 per common share, on 262 million weighted-average common shares outstanding, compared to $155 million, or $0.63 per common share, on 246 million weighted-average common shares outstanding, for Q2 2023.
    • Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $185 million, or $0.71 per common share, compared to $183 million, or $0.74 per common share, for Q2 2023.
    • Funds Available for Distribution ("FAD") for the quarter of $177 million, or $0.68 per common share, compared to FAD of $173 million, or $0.70 per common share, for Q2 2023.
    • Completed $221 million in Q2 new investments consisting of $115 million in real estate acquisitions and $106 million in real estate loans.
    • Issued 8 million common shares for gross proceeds of $245 million.
    • Repaid $400 million of senior unsecured notes.
    • Completed $373 million in new investments in Q3 2024 to date, which includes the assumption of a $243 million mortgage loan.

    Nareit FFO, AFFO and FAD are supplemental non-GAAP financial measures that the Company believes are useful in evaluating the performance of real estate investment trusts ("REITs"). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.

    CEO COMMENTS

    Taylor Pickett, Omega's Chief Executive Officer, stated, "Our second quarter financial performance showed strong sequential improvement, driven primarily by accretive investments and the resolution of portfolio restructurings."

    Mr. Pickett continued, "We have accretively invested approximately $648 million year-to-date through July and the pipeline remains strong. Additionally, we have seen continued improvement in the operating metrics of our tenants, with a further uptick in average portfolio coverage and a meaningful decline in the percentage of operators below 1.0x EBITDAR coverage. As a result, we are increasing our 2024 AFFO guidance to be between $2.78 and $2.84 per share from our previous guidance of between $2.70 and $2.80 per share."

    Mr. Pickett concluded, "This industry has faced some of its most challenging times in the past four years. During this period, our operators and their brave staff have worked diligently to care for a particularly vulnerable segment of our society. As operations improve and financial challenges recede, we hope that both federal and state governments will continue to support this vital part of the healthcare continuum and enable operators to remain focused on providing exceptional clinical care."

    SECOND QUARTER 2024 RESULTS

    Revenues – Revenues for the quarter ended June 30, 2024 totaled $252.7 million, an increase of $2.6 million over the same period in 2023. The increase primarily resulted from (i) revenue from new investments completed throughout 2023 and 2024 and (ii) the timing and impact of operator restructurings and transitions. The increase was partially offset by a decrease in revenue from asset sales completed throughout 2023 and 2024.

    Expenses – Expenses for the quarter ended June 30, 2024 totaled $149.9 million, a decrease of $51.5 million over the same period in 2023. The decrease primarily resulted from (i) a decrease in provision for credit losses, (ii) a decrease in impairment on real estate properties, (iii) a decrease in depreciation and amortization expense and (iv) a decrease in interest expense, partially offset by an increase in acquisition, merger and transition related costs.

    Other Income and Expense – Other income for the quarter ended June 30, 2024 totaled $16.1 million, an increase of $2.8 million over the same period in 2023. The increase primarily resulted from (i) an increase in other income – net and (ii) an increase in gain on assets sold, partially offset by an increase in loss on debt extinguishment.

    Net Income – Net income for the quarter ended June 30, 2024 totaled $117.1 million, an increase of $55.6 million over the same period in 2023. The net increase primarily resulted from the aforementioned (i) $51.5 million decrease in total expenses, (ii) $2.8 million increase in other income and expense, (iii) $2.6 million increase in total revenue and (iv) a $0.9 million decrease in income from unconsolidated joint ventures.

    2024 SECOND QUARTER PORTFOLIO AND RECENT ACTIVITY

    Operator Updates:

    LaVie – As previously disclosed, LaVie Care Centers, LLC ("LaVie") filed for Chapter 11 bankruptcy protection in June 2024. The Company committed $10 million of debtor-in-possession financing to LaVie ($4.5 million outstanding on June 30, 2024), in order to support sufficient liquidity to effectively operate its facilities during bankruptcy. As part of our debtor-in-possession loan commitment, during the period of bankruptcy protection, LaVie is required to pay the Company full contractual rent on the properties LaVie continues to lease from Omega. Prior to its filing bankruptcy, LaVie paid $1.5 million in each of April and May 2024. Following the bankruptcy filing, LaVie paid full contractual rent of approximately $3.0 million in each of June and July 2024.

    Maplewood – In July 2024, Omega reached an agreement with the estate of the deceased principal and CEO of Maplewood Senior Living ("Maplewood") to transition control of Maplewood, including assumption of Omega's lease and loan agreements, to key members of the existing Maplewood management team. The agreement is subject to court approval. In the second quarter of 2024, Maplewood paid $11.8 million in rent (compared to $11.3 million in the first quarter). In July 2024, Maplewood paid $4.0 million in rent.

    Guardian – In April 2024, the Company transitioned its remaining six Guardian facilities to a new operator for minimum initial annual contractual rent of $5.5 million with the potential to increase contractual rent dependent on revenue received by the operator. The Company received contractual rent of $2.8 million from the new operator during the second quarter of 2024, which consisted of $1.3 million of base minimum rent and $1.5 million of incremental revenue based on the revenue received by the operator.

    New Investments:

    The following table presents investment activity for the three and six months ended June 30, 2024:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

    Investment Activity ($000's)

     

    June 30, 2024

     

    June 30, 2024

     

     

    $ Amount

     

    %

     

    $ Amount

     

    %

    Real property

     

    $

    114,727

     

    45.2

    %

     

    $

    127,996

     

    38.9

    %

    Real estate loans receivable

     

     

    105,895

     

    41.7

    %

     

     

    147,137

     

    44.7

    %

    Total real property and loan investments

     

     

    220,622

     

    86.9

    %

     

     

    275,133

     

    83.6

    %

    Construction-in-progress

     

     

    25,901

     

    10.2

    %

     

     

    40,689

     

    12.4

    %

    Capital expenditures

     

     

    7,456

     

    2.9

    %

     

     

    13,120

     

    4.0

    %

    Total capital investments

     

     

    33,357

     

    13.1

    %

     

     

    53,809

     

    16.4

    %

    Total

     

    $

    253,979

     

    100.0

    %

     

    $

    328,942

     

    100.0

    %

    $115 Million in Real Estate Acquisitions – In three separate second quarter transactions, the Company acquired 34 facilities for aggregate consideration of $114.7 million and leased them to an existing operator and two new operators. The investments have a combined initial annual cash yield of 10.4% with annual escalators ranging from 2.0% to 2.5%.

    $106 Million in Real Estate Loans – In four separate second quarter transactions, the Company funded $105.9 million in mortgage and other real estate loans. The loans have a weighted-average interest rate of 10.4%.

    $373 Million in Q3 2024 Investments – As of July 31, 2024, the Company closed on $373.0 million in new investments, comprised of:

    $5 Million Real Estate Acquisition – In July 2024, the Company acquired a facility in the U.K. for $5.1 million and leased the facility to an existing operator. The investment has an initial annual cash yield of 10.0% with an escalator of 2.5%.

    $341 Million Real Estate Acquisition – In July 2024, the Company acquired the remaining 51% equity interest in the unconsolidated Cindat joint venture ("Cindat JV") for total cash consideration of $97.4 million, excluding related transaction costs, and the assumption of a $243.2 million mortgage loan, which can be repaid without a prepayment penalty beginning November 2025. The mortgage loan bears interest at SONIA plus an applicable margin of 5.38% with a 10.38% interest rate ceiling. The Company's 49% ownership interest in the unconsolidated Cindat JV was valued at $95.3 million at June 30, 2024. With the acquisition of the remaining 51% equity and assumption of the mortgage loan, the Company's total investment in the 63 U.K. facilities is approximately $435.9 million. The 63 facilities are leased to two operators for current annual contractual rent of $43.6 million with minimum escalators, between 1.0% to 2.0%. Following the acquisition, the Company owns 100% of the entity, and accordingly in the third quarter will consolidate the Cindat JV's results in its financial statements.

    $27 Million Real Estate Loan – In July 2024, the Company funded a $27.3 million real estate loan. The loan bears interest at 10% and has a 6-year term.

    Through July 31, 2024, the Company has completed $648.1 million in new investments in 2024, excluding investments in construction-in-progress and capital expenditures.

    Asset Sales and Impairments:

    $35 Million in Asset Sales – In the second quarter of 2024, the Company sold five facilities for $34.8 million in cash, recognizing a gain of $12.9 million.

    Impairments – During the second quarter of 2024, the Company recorded an $8.2 million net impairment charge to reduce the net book value of four facilities to their estimated fair value.

    Assets Held for Sale – As of June 30, 2024, the Company had 15 facilities classified as assets held for sale, totaling $76.6 million in net book value. In July, the Company sold two of the 15 facilities for $11.8 million in cash proceeds.

    OPERATOR COVERAGE DATA

    The following tables present operator revenue mix, census and coverage data based on information provided by the Company's operators for the indicated periods. The Company has not independently verified this information, and it is providing this data for informational purposes only.

     

     

     

     

     

     

     

     

    Operator Revenue Mix (1)

     

     

     

    Medicare /

    Private /

     

     

    Medicaid

    Insurance

    Other

    Three-months ended March 31, 2024

     

    52.7

    %

    30.0

    %

    17.3

    %

    Three-months ended December 31, 2023

     

    55.3

    %

    28.0

    %

    16.7

    %

    Three-months ended September 30, 2023

     

    55.5

    %

    28.0

    %

    16.5

    %

    Three-months ended June 30, 2023

     

    54.0

    %

    30.0

    %

    16.0

    %

    Three-months ended March 31, 2023

     

    53.0

    %

    31.8

    %

    15.2

    %

    (1)

    Excludes all facilities considered non-core and does not include federal stimulus revenue. For non-core definition, see Second Quarter 2024 Financial Supplemental posted in the "Quarterly Supplements" section of Omega's website.

     

     

     

     

     

     

     

     

     

     

    Coverage Data

     

     

     

    Before

    After

     

     

    Occupancy (2)

    Management

    Management

    Operator Census and Coverage (1)

     

     

    Fees (3)

    Fees (4)

    Twelve-months ended March 31, 2024

     

    80.2

    %

    1.78x

    1.42x

    Twelve-months ended December 31, 2023

     

    79.6

    %

    1.69x

    1.33x

    Twelve-months ended September 30, 2023

     

    79.1

    %

    1.63x

    1.28x

    Twelve-months ended June 30, 2023

     

    78.6

    %

    1.50x

    1.15x

    Twelve-months ended March 31, 2023

     

    78.0

    %

    1.44x

    1.10x

    (1)  

    Excludes facilities considered non-core. For information regarding non-core facilities, see the most recent Quarterly Supplement posted on the Company's website.

    (2)  

    Based on available (operating) beds.

    (3)  

    Represents EBITDARM of our operators, defined as earnings before interest, taxes, depreciation, amortization, Rent costs and management fees for the applicable period, divided by the total Rent payable to the Company by its operators during such period. "Rent" refers to the total monthly contractual rent and mortgage interest due under the Company's lease and mortgage agreements over the applicable period.

    (4)  

    Represents EBITDAR of our operators, defined as earnings before interest, taxes, depreciation, amortization, and Rent (as defined in footnote 3) expense for the applicable period, divided by the total Rent payable to the Company by its operators during such period. Assumes a management fee of 4%.

    FINANCING ACTIVITIES

    Dividend Reinvestment and Common Stock Purchase Plan and ATM Program – The following is a summary of the 2024 quarterly Common Stock Purchase Plan and ATM Program through June 30:

     

     

     

     

     

     

     

     

     

     

    Dividend Reinvestment and Common Stock Purchase Plan for 2024

     

    (in thousands, except price per share)

     

     

     

     

     

     

     

     

     

     

    Q1

     

    Q2

     

    Total

    Number of shares

     

    29

     

     

    413

     

     

    442

    Average price per share

    $

    30.44

     

    $

    31.52

     

    $

    31.45

    Gross proceeds

    $

    882

     

    $

    13,015

     

    $

    13,897

     

     

     

     

     

     

     

     

     

     

    ATM Program for 2024

     

    (in thousands, except price per share)

     

     

     

     

     

     

     

     

     

     

    Q1

     

    Q2

     

    Total

    Number of shares

     

    1,041

     

     

    7,212

     

     

    8,253

    Average price per share

    $

    31.02

     

    $

    32.16

     

    $

    32.01

    Gross proceeds

    $

    32,295

     

    $

    231,920

     

    $

    264,215

    BALANCE SHEET AND LIQUIDITY

    As of June 30, 2024, the Company had $4.7 billion of outstanding indebtedness with a weighted-average annual interest rate of 4.3%. The Company's indebtedness consisted of an aggregate principal amount of $4.2 billion of senior unsecured notes, $478.5 million of unsecured term loans and $70.2 million of borrowings outstanding under its unsecured revolving credit facility. As of June 30, 2024, total cash and cash equivalents were $35.2 million, and the Company had $1.4 billion of undrawn capacity under its unsecured revolving credit facility.

    $400 Million Note Repayment – On April 1, 2024, the Company repaid its $400.0 million 4.950% senior notes that matured on April 1, 2024, from invested cash balances and borrowings under its unsecured revolving credit facility.

    DIVIDENDS

    On July 24, 2024, the Board of Directors declared a quarterly cash dividend of $0.67 per share, to be paid August 15, 2024, to common stockholders of record as of the close of business on August 5, 2024.

    2024 AFFO GUIDANCE INCREASED

    The Company increased the guidance range of its 2024 Adjusted FFO to a range of $2.78 to $2.84 per diluted share from the previous range of $2.70 and $2.80 per diluted share.

    The Company's revised Adjusted FFO guidance for 2024 includes the annual impact of $648 million in new investments completed through July 2024, assumes quarterly G&A expense of approximately $11.5 million to $13.5 million in Q3 and Q4, $77 million in asset sales, timely completion of anticipated operator restructurings and transitions, no material changes in market interest rates, and that no additional operators are placed on a cash-basis for revenue recognition. It excludes additional acquisitions and asset sales, certain revenue and expense items, interest refinancing expense, additional capital transactions, acquisition costs, and additional provisions for credit losses, if any.

    The Company's guidance is based on several assumptions including those noted above, which are subject to change and many of which are outside the Company's control. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the timing of collection of rental obligations from operators on a cash basis, the timing and completion of acquisitions, divestitures, restructurings and capital and financing transactions may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results. The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.

    The Company does not provide a reconciliation for its Adjusted FFO guidance to GAAP net income because it is unable to determine meaningful or accurate estimates of reconciling items without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and/or amounts of various items that would impact future net income. This includes, but is not limited to, changes in the provision for credit losses, real estate impairments, acquisition, merger and transition related costs, straight-line write-offs, gain/loss on assets sold, etc. In particular, the Company is unable to predict with reasonable certainty the amount of the change in the provision for credit losses in future periods, which is often a significant reconciling adjustment.

    ADDITIONAL INFORMATION

    Additional information regarding the Company can be found in its Second Quarter 2024 Financial Supplemental posted under "Financial Info" in the Investors section of Omega's website. The information contained on, or that may be accessed through, Omega's website, including the information contained in the aforementioned supplemental, is not incorporated by any reference into, and is not part of, this document.

    CONFERENCE CALL

    The Company will be conducting a conference call on Friday, August 2, 2024, at 10 a.m. Eastern time to review the Company's 2024 second quarter results and current developments. Analysts and investors within the U.S. interested in participating are invited to call (877) 407-9124. The international toll-free dial-in number is (201) 689-8584. Ask the operator to be connected to the "Omega Healthcare's Second Quarter 2024 Earnings Call."

    To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the "Omega Healthcare Investors, Inc. 2Q Earnings Call" hyper-link on the "Investors" page of Omega's website. Webcast replays of the call will be available on Omega's website for a minimum of two weeks following the call. Additionally, a copy of the earnings release will be available in the "Financial Info" section and "SEC Filings" section on the "Investors" page of Omega's website.

    * * * * * *

    Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

    Forward-Looking Statements and Cautionary Language

    This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega's or its tenants', operators', borrowers' or managers' expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations.

    Omega's actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of Omega's properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) the long-term impacts of the Novel coronavirus ("COVID-19") pandemic on our business and the business of our operators, including the levels of staffing shortages, increased costs and decreased occupancy experienced by operators of skilled nursing facilities ("SNFs") and assisted living facilities ("ALFs") arising from the pandemic, the ability of our operators to comply with infection control and vaccine protocols and to manage facility infection rates or future infectious diseases, and the sufficiency of government support and reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including federal minimum staffing requirements for SNFs that may further exacerbate labor and occupancy challenges for Omega's operators; (iv) the ability of any of Omega's operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega's mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes in tax laws and regulations affecting real estate investment trusts ("REITs"), including as the result of any policy changes driven by the current focus on capital providers to the healthcare industry; (vi) Omega's ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and ALF markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega's credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (xi) changes in the financial position of Omega's operators; (xii) the effect of economic and market conditions generally, and particularly in the healthcare industry; (xiii) changes in interest rates and the impact of inflation; (xiv) the timing, amount and yield of any additional investments; (xv) Omega's ability to maintain its status as a REIT; (xvi) the effect of other factors affecting our business or the businesses of Omega's operators that are beyond Omega's or operators' control, including natural disasters, other health crises or pandemics and governmental action, particularly in the healthcare industry, and (xvii) other factors identified in Omega's filings with the Securities and Exchange Commission. Statements regarding future events and developments and Omega's future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward looking statements.

    We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

    OMEGA HEALTHCARE INVESTORS, INC.

    CONSOLIDATED BALANCE SHEETS

    (in thousands, except per share amounts)

     

     

     

     

     

     

     

     

     

    June 30,

     

    December 31,

     

     

    2024

     

     

    2023

     

     

     

    (Unaudited)

     

     

     

    ASSETS

     

     

     

     

     

     

    Real estate assets

     

     

     

     

     

     

    Buildings and improvements

     

    $

    6,925,123

     

     

    $

    6,879,034

     

    Land

     

     

    876,762

     

     

     

    867,486

     

    Furniture and equipment

     

     

    473,021

     

     

     

    467,393

     

    Construction in progress

     

     

    185,487

     

     

     

    138,410

     

    Total real estate assets

     

     

    8,460,393

     

     

     

    8,352,323

     

    Less accumulated depreciation

     

     

    (2,583,159

    )

     

     

    (2,464,227

    )

    Real estate assets – net

     

     

    5,877,234

     

     

     

    5,888,096

     

    Investments in direct financing leases – net

     

     

    9,437

     

     

     

    8,716

     

    Real estate loans receivable – net

     

     

    1,378,798

     

     

     

    1,212,162

     

    Investments in unconsolidated joint ventures

     

     

    185,270

     

     

     

    188,409

     

    Assets held for sale

     

     

    76,627

     

     

     

    81,546

     

    Total real estate investments

     

     

    7,527,366

     

     

     

    7,378,929

     

    Non-real estate loans receivable – net

     

     

    234,562

     

     

     

    275,615

     

    Total investments

     

     

    7,761,928

     

     

     

    7,654,544

     

     

     

     

     

     

     

     

    Cash and cash equivalents

     

     

    35,193

     

     

     

    442,810

     

    Restricted cash

     

     

    3,938

     

     

     

    1,920

     

    Contractual receivables – net

     

     

    10,360

     

     

     

    11,888

     

    Other receivables and lease inducements

     

     

    230,428

     

     

     

    214,657

     

    Goodwill

     

     

    643,786

     

     

     

    643,897

     

    Other assets

     

     

    162,913

     

     

     

    147,686

     

    Total assets

     

    $

    8,848,546

     

     

    $

    9,117,402

     

     

     

     

     

     

     

     

    LIABILITIES AND EQUITY

     

     

     

     

     

     

    Revolving credit facility

     

    $

    70,226

     

     

    $

    20,397

     

    Secured borrowings

     

     

    —

     

     

     

    61,963

     

    Senior notes and other unsecured borrowings – net

     

     

    4,590,378

     

     

     

    4,984,956

     

    Accrued expenses and other liabilities

     

     

    287,354

     

     

     

    287,795

     

    Total liabilities

     

     

    4,947,958

     

     

     

    5,355,111

     

     

     

     

     

     

     

     

    Preferred stock $1.00 par value authorized – 20,000 shares, issued and outstanding – none

     

     

    —

     

     

     

    —

     

    Common stock $.10 par value authorized – 350,000 shares, issued and outstanding – 254,023 shares as of June 30, 2024 and 245,282 shares as of December 31, 2023

     

     

    25,402

     

     

     

    24,528

     

    Additional paid-in capital

     

     

    6,951,244

     

     

     

    6,671,198

     

    Cumulative net earnings

     

     

    3,861,804

     

     

     

    3,680,581

     

    Cumulative dividends paid

     

     

    (7,161,897

    )

     

     

    (6,831,061

    )

    Accumulated other comprehensive income

     

     

    34,345

     

     

     

    29,338

     

    Total stockholders' equity

     

     

    3,710,898

     

     

     

    3,574,584

     

    Noncontrolling interest

     

     

    189,690

     

     

     

    187,707

     

    Total equity

     

     

    3,900,588

     

     

     

    3,762,291

     

    Total liabilities and equity

     

    $

    8,848,546

     

     

    $

    9,117,402

     

    OMEGA HEALTHCARE INVESTORS, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    Unaudited

    (in thousands, except per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended

     

     

    Six Months Ended

     

     

    June 30,

     

     

    June 30,

     

     

    2024

     

     

    2023

     

     

     

    2024

     

     

    2023

     

    Revenues

     

     

     

     

     

     

     

     

     

     

     

     

     

    Rental income

     

    $

    210,402

     

     

    $

    215,267

     

     

     

    $

    413,606

     

     

    $

    400,622

     

    Real estate tax and ground lease income

     

     

    3,913

     

     

     

    4,088

     

     

     

     

    7,630

     

     

     

    8,064

     

    Real estate loans interest income

     

     

    30,958

     

     

     

    23,979

     

     

     

     

    59,697

     

     

     

    47,376

     

    Non-real estate loans interest income

     

     

    7,084

     

     

     

    5,253

     

     

     

     

    14,181

     

     

     

    10,276

     

    Miscellaneous income

     

     

    388

     

     

     

    1,600

     

     

     

     

    930

     

     

     

    2,051

     

    Total revenues

     

     

    252,745

     

     

     

    250,187

     

     

     

     

    496,044

     

     

     

    468,389

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Expenses

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    74,234

     

     

     

    82,018

     

     

     

     

    148,791

     

     

     

    163,210

     

    General and administrative

     

     

    12,453

     

     

     

    12,854

     

     

     

     

    24,247

     

     

     

    24,268

     

    Real estate tax and ground lease expense

     

     

    4,257

     

     

     

    4,423

     

     

     

     

    8,566

     

     

     

    8,788

     

    Stock-based compensation expense

     

     

    9,188

     

     

     

    8,806

     

     

     

     

    18,415

     

     

     

    17,550

     

    Acquisition, merger and transition related costs

     

     

    1,780

     

     

     

    423

     

     

     

     

    4,383

     

     

     

    1,062

     

    Impairment on real estate properties

     

     

    8,182

     

     

     

    21,114

     

     

     

     

    13,474

     

     

     

    60,102

     

    (Recovery) provision for credit losses

     

     

    (14,172

    )

     

     

    12,967

     

     

     

     

    (5,702

    )

     

     

    8,910

     

    Interest expense

     

     

    50,604

     

     

     

    55,525

     

     

     

     

    104,748

     

     

     

    110,818

     

    Interest – amortization of deferred financing costs

     

     

    3,362

     

     

     

    3,251

     

     

     

     

    7,038

     

     

     

    6,504

     

    Total expenses

     

     

    149,888

     

     

     

    201,381

     

     

     

     

    323,960

     

     

     

    401,212

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Other income (expense)

     

     

     

     

     

     

     

     

     

     

     

     

     

    Other income – net

     

     

    3,363

     

     

     

    1,029

     

     

     

     

    8,639

     

     

     

    3,749

     

    Loss on debt extinguishment

     

     

    (213

    )

     

     

    —

     

     

     

     

    (1,496

    )

     

     

    (6

    )

    Gain on assets sold – net

     

     

    12,911

     

     

     

    12,243

     

     

     

     

    11,520

     

     

     

    25,880

     

    Total other income

     

     

    16,061

     

     

     

    13,272

     

     

     

     

    18,663

     

     

     

    29,623

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Income before income tax expense and income from unconsolidated joint ventures

     

     

    118,918

     

     

     

    62,078

     

     

     

     

    190,747

     

     

     

    96,800

     

    Income tax expense

     

     

    (1,980

    )

     

     

    (1,626

    )

     

     

     

    (4,561

    )

     

     

    (334

    )

    Income from unconsolidated joint ventures

     

     

    141

     

     

     

    1,069

     

     

     

     

    239

     

     

     

    1,900

     

    Net income

     

     

    117,079

     

     

     

    61,521

     

     

     

     

    186,425

     

     

     

    98,366

     

    Net income attributable to noncontrolling interest

     

     

    (3,217

    )

     

     

    (1,665

    )

     

     

     

    (5,202

    )

     

     

    (2,568

    )

    Net income available to common stockholders

     

    $

    113,862

     

     

    $

    59,856

     

     

     

    $

    181,223

     

     

    $

    95,798

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings per common share available to common stockholders:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income available to common stockholders

     

    $

    0.46

     

     

    $

    0.25

     

     

     

    $

    0.73

     

     

    $

    0.41

     

    Diluted:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income available to common stockholders

     

    $

    0.45

     

     

    $

    0.25

     

     

     

    $

    0.72

     

     

    $

    0.40

     

    Dividends declared per common share

     

    $

    0.67

     

     

    $

    0.67

     

     

     

    $

    1.34

     

     

    $

    1.34

     

    OMEGA HEALTHCARE INVESTORS, INC.

    Nareit FFO, Adjusted FFO and FAD Reconciliation

    Unaudited

    (in thousands, except per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

     

    June 30,

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income (1)

     

    $

    117,079

     

     

    $

    61,521

     

     

    $

    186,425

     

     

    $

    98,366

     

    Deduct gain from real estate dispositions

     

     

    (12,911

    )

     

     

    (12,243

    )

     

     

    (11,520

    )

     

     

    (25,880

    )

    Sub-total

     

     

    104,168

     

     

     

    49,278

     

     

     

    174,905

     

     

     

    72,486

     

    Elimination of non-cash items included in net income:

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    74,234

     

     

     

    82,018

     

     

     

    148,791

     

     

     

    163,210

     

    Depreciation - unconsolidated joint ventures

     

     

    2,531

     

     

     

    2,743

     

     

     

    5,067

     

     

     

    5,427

     

    Add back provision for impairments on real estate properties

     

     

    8,182

     

     

     

    21,114

     

     

     

    13,474

     

     

     

    60,102

     

    Nareit funds from operations ("Nareit FFO")

     

    $

    189,115

     

     

    $

    155,153

     

     

    $

    342,237

     

     

    $

    301,225

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted-average common shares outstanding, basic

     

     

    249,366

     

     

     

    236,233

     

     

     

    247,719

     

     

     

    235,594

     

    Restricted stock and PRSUs

     

     

    4,583

     

     

     

    2,893

     

     

     

    4,170

     

     

     

    2,139

     

    Omega OP Units

     

     

    7,585

     

     

     

    6,974

     

     

     

    7,511

     

     

     

    6,912

     

    Weighted-average common shares outstanding, diluted

     

     

    261,534

     

     

     

    246,100

     

     

     

    259,400

     

     

     

    244,645

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Nareit funds from operations available per share

     

    $

    0.72

     

     

    $

    0.63

     

     

    $

    1.32

     

     

    $

    1.23

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjustments to calculate adjusted funds from operations

     

     

     

     

     

     

     

     

     

     

     

     

    Nareit FFO

     

    $

    189,115

     

     

    $

    155,153

     

     

    $

    342,237

     

     

    $

    301,225

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Stock-based compensation expense

     

     

    9,188

     

     

     

    8,806

     

     

     

    18,415

     

     

     

    17,550

     

    Acquisition, merger and transition related costs

     

     

    1,780

     

     

     

    423

     

     

     

    4,383

     

     

     

    1,062

     

    Non-recognized cash interest

     

     

    307

     

     

     

    2,322

     

     

     

    607

     

     

     

    4,418

     

    Loss on debt extinguishment

     

     

    213

     

     

     

    —

     

     

     

    1,496

     

     

     

    6

     

    Non-recurring expense

     

     

    —

     

     

     

    1,893

     

     

     

    232

     

     

     

    1,893

     

    Uncollectible accounts receivable (2)

     

     

    —

     

     

     

    901

     

     

     

    —

     

     

     

    13,401

     

    Deduct:

     

     

     

     

     

     

     

     

     

     

     

     

    Non-cash (recovery) provision for credit losses

     

     

    (12,989

    )

     

     

    15,409

     

     

     

    (3,349

    )

     

     

    13,968

     

    Non-recurring revenue

     

     

    (2,649

    )

     

     

    (1,500

    )

     

     

    (2,938

    )

     

     

    (10,315

    )

    Unconsolidated JV related non-recurring revenue

     

     

    —

     

     

     

    (178

    )

     

     

    —

     

     

     

    (178

    )

    Adjusted funds from operations ("AFFO") (1)(3)

     

    $

    184,965

     

     

    $

    183,229

     

     

    $

    361,083

     

     

    $

    343,030

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjustments to calculate funds available for distribution

     

     

     

     

     

     

     

     

     

     

     

     

    Non-cash expense

     

    $

    2,750

     

     

    $

    2,222

     

     

    $

    5,947

     

     

    $

    4,446

     

    Capitalized interest

     

     

    (1,758

    )

     

     

    (991

    )

     

     

    (3,276

    )

     

     

    (1,899

    )

    Non-cash revenue

     

     

    (9,335

    )

     

     

    (11,624

    )

     

     

    (19,215

    )

     

     

    (25,719

    )

    Funds available for distribution ("FAD") (1)(3)

     

    $

    176,622

     

     

    $

    172,836

     

     

    $

    344,539

     

     

    $

    319,858

     

    _______________________
    (1)  

    The three and six months ended June 30, 2024 include the application of $0.1 million and $0.6 million, respectively, of security deposits (letters of credit and cash deposits) in revenue. The three and six months ended June 30, 2023 include the application of $0.3 million and $5.5 million, respectively, of security deposits (letters of credit and cash deposits) in revenue.

    (2)  

    The six months ended June 30, 2023 includes a $12.5 million lease inducement write-off recorded as a reduction to rental income related to the Maplewood option termination fee. All other amounts represent straight-line accounts receivable write-offs also recorded as a reduction to rental income.

    (3)  

    Adjusted funds from operations per share and funds available for distribution per share can be calculated using weighted-average common shares outstanding, diluted, as shown above.

    Nareit Funds From Operations ("Nareit FFO"), Adjusted FFO and Funds Available for Distribution ("FAD") are non-GAAP financial measures. As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

    The Company calculates and reports Nareit FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts ("Nareit"), and consequently, Nareit FFO is defined as net income (computed in accordance with GAAP), adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization and impairments on real estate assets, and after adjustments for unconsolidated partnerships and joint ventures and changes in the fair value of warrants. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect funds from operations on the same basis. Revenue recognized based on the application of security deposits and letters of credit or based on the ability to offset against other financial instruments is included within Nareit FFO. The Company believes that Nareit FFO, Adjusted FFO and FAD are important supplemental measures of its operating performance. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. The term funds from operations was designed by the real estate industry to address this issue. Funds from operations described herein is not necessarily comparable to funds from operations of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.

    Adjusted FFO is calculated as Nareit FFO excluding the impact of non-cash stock-based compensation and certain revenue and expense items (e.g., acquisition, merger and transition related costs, write-off of straight-line accounts receivable, recoveries and provisions for credit losses (excluding certain cash recoveries on impaired loans), cash interest received but not included in revenue, non-recognized cash interest, severance, legal reserve expenses, etc.). FAD is calculated as Adjusted FFO less non-cash expense, such as the amortization of deferred financing costs, and non-cash revenue, such as straight-line rent. The Company believes these measures provide an enhanced measure of the operating performance of the Company's core portfolio as a REIT. The Company's computation of Adjusted FFO and FAD may not be comparable to the Nareit definition of funds from operations or to similar measures reported by other REITs, but the Company believes that they are appropriate measures for this Company.

    The Company uses these non-GAAP measures among the criteria to measure the operating performance of its business. The Company also uses FAD among the performance metrics for performance-based compensation of officers. The Company further believes that by excluding the effect of depreciation, amortization, impairments on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs, and which may be of limited relevance in evaluating current performance, funds from operations can facilitate comparisons of operating performance between periods. The Company offers these measures to assist the users of its financial statements in analyzing its operating performance. These non-GAAP measures are not measures of financial performance under GAAP and should not be considered as measures of liquidity or cash flow, alternatives to net income or indicators of any other performance measure determined in accordance with GAAP. Investors and potential investors in the Company's securities should not rely on these non-GAAP measures as substitutes for any GAAP measure, including net income.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240801452932/en/

    Get the next $OHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OHI

    DatePrice TargetRatingAnalyst
    1/29/2026$45.00Overweight → Equal Weight
    Wells Fargo
    1/9/2026$54.00Buy
    Goldman
    1/9/2026$45.00Outperform → Market Perform
    BMO Capital Markets
    11/18/2025$50.00Buy
    UBS
    10/1/2025$50.00Overweight
    Cantor Fitzgerald
    7/14/2025$41.00Equal Weight → Overweight
    Wells Fargo
    3/27/2025$41.00 → $39.00Overweight → Equal Weight
    Wells Fargo
    12/9/2024$45.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $OHI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Omega Health downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Omega Health from Overweight to Equal Weight and set a new price target of $45.00

    1/29/26 7:00:20 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Goldman initiated coverage on Omega Health with a new price target

    Goldman initiated coverage of Omega Health with a rating of Buy and set a new price target of $54.00

    1/9/26 9:06:22 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Health downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded Omega Health from Outperform to Market Perform and set a new price target of $45.00

    1/9/26 8:51:22 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Pickett C Taylor

    4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)

    1/15/26 6:30:08 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by CHIEF LEGAL OFFICER Makode Gail D

    4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)

    1/15/26 6:30:10 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER Stephenson Robert O

    4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)

    1/15/26 6:30:06 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Omega Reports Fourth Quarter and Full Year 2025 Results and Recent Developments

    Completed $334 Million in New Investments in Q4 2025 Issued $223 Million in Equity in Q4 2025 Repaid $1.27 Billion of Aggregate Debt in Q4 2025 Providing 2026 Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter and year ended December 31, 2025. FOURTH QUARTER 2025 AND RECENT HIGHLIGHTS Net income for the quarter of $172 million, or $0.55 per diluted share, compared to $116 million, or $0.41 per diluted share, for Q4 2024. Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $250 million, or $0.80 per diluted share, on 313 million weighted-average common shares outstanding,

    2/4/26 4:15:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Announces Quarterly Dividend

    Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Tuesday, February 17, 2026, to common stockholders of record as of the close of business on Monday, February 9, 2026. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.om

    1/29/26 3:00:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Announces Fourth Quarter Earnings Release Date and Conference Call

    Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2025, on Wednesday, February 4, 2026, after market close. In conjunction with its release, Omega will conduct a conference call on Thursday, February 5, 2026, at 10 a.m. Eastern Time to review its 2025 fourth quarter results and current developments. Investors and other interested parties may access the conference call in the following ways: At the Company's website: https://www.omegahealthcare.com/ Via webcast: https://events.q4inc.com/attendee/547391410. Joining via webcast is recommended for those who will not be asking questions.

    1/6/26 2:30:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Gupta Vikas bought $494,118 worth of shares (11,500 units at $42.97), increasing direct ownership by 506% to 13,773 units (SEC Form 4)

    4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)

    11/6/25 4:15:16 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    CHIEF EXECUTIVE OFFICER Pickett C Taylor bought $862,856 worth of shares (20,000 units at $43.14) (SEC Form 4)

    4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)

    11/6/25 4:15:14 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    SEC Filings

    View All

    Omega Healthcare Investors Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)

    2/4/26 4:18:17 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Healthcare Investors Inc. filed SEC Form 8-K: Leadership Update

    8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)

    1/7/26 4:16:18 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    SEC Form SCHEDULE 13G filed by Omega Healthcare Investors Inc.

    SCHEDULE 13G - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)

    11/10/25 8:49:00 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Leadership Updates

    Live Leadership Updates

    View All

    Maplewood and Inspīr Senior Living Toast to Culinary Excellence with Three National Awards and the Return of Culinary Visionary Jason Wallin as Corporate Director of Culinary Services

    NEW YORK, Aug. 13, 2025 /PRNewswire/ -- In a celebration of artistry, innovation, and the transformative power of dining, Maplewood Senior Living and its luxury urban brand, Inspīr, proudly announce that three of their executive chefs have earned national recognition in the 2025 DISHED Senior Living Dining Innovation Awards presented by WTWH Healthcare, a WTWH Media, LLC company.  Adding to this moment of distinction, Maplewood welcomes back seasoned culinary leader Jason Wallin as Corporate Director of Culinary Services, signaling an exciting new chapter in their commitment t

    8/13/25 9:23:00 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

    Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

    7/3/25 8:00:00 AM ET
    $BKD
    $GMRE
    $NTST
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Maplewood Senior Living Strengthens Leadership Team Across Its Maplewood and Inspīr Brands to Support Strategic Growth and Future Innovation

    WESTPORT, Conn., June 24, 2025 /PRNewswire/ -- Maplewood Senior Living, a leading provider of premium senior living, is proud to announce a series of strategic leadership promotions and appointments designed to support the organization's continued growth, elevate the resident experience, and position the company for long-term success. Operating two distinct brands—Maplewood Senior Living, known for its warm, neighborhood-based communities throughout the Northeast and Midwest, and Inspīr, its ultra-luxury brand located in premier urban markets—Maplewood is aligning its leadersh

    6/24/25 10:07:00 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Financials

    Live finance-specific insights

    View All

    Omega Reports Fourth Quarter and Full Year 2025 Results and Recent Developments

    Completed $334 Million in New Investments in Q4 2025 Issued $223 Million in Equity in Q4 2025 Repaid $1.27 Billion of Aggregate Debt in Q4 2025 Providing 2026 Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter and year ended December 31, 2025. FOURTH QUARTER 2025 AND RECENT HIGHLIGHTS Net income for the quarter of $172 million, or $0.55 per diluted share, compared to $116 million, or $0.41 per diluted share, for Q4 2024. Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $250 million, or $0.80 per diluted share, on 313 million weighted-average common shares outstanding,

    2/4/26 4:15:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Announces Quarterly Dividend

    Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Tuesday, February 17, 2026, to common stockholders of record as of the close of business on Monday, February 9, 2026. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.om

    1/29/26 3:00:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    Omega Announces Fourth Quarter Earnings Release Date and Conference Call

    Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2025, on Wednesday, February 4, 2026, after market close. In conjunction with its release, Omega will conduct a conference call on Thursday, February 5, 2026, at 10 a.m. Eastern Time to review its 2025 fourth quarter results and current developments. Investors and other interested parties may access the conference call in the following ways: At the Company's website: https://www.omegahealthcare.com/ Via webcast: https://events.q4inc.com/attendee/547391410. Joining via webcast is recommended for those who will not be asking questions.

    1/6/26 2:30:00 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    $OHI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Omega Healthcare Investors Inc.

    SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)

    10/18/24 9:51:11 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Omega Healthcare Investors Inc. (Amendment)

    SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)

    1/29/24 12:29:16 PM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Omega Healthcare Investors Inc. (Amendment)

    SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)

    2/10/23 11:02:31 AM ET
    $OHI
    Real Estate Investment Trusts
    Real Estate